Policy Name Effective Date Revision Date Next Review Date
D
mp-026 Drug Levels and Antibody Testing for Infliximab, Adalimumab, Vedolizumab and Ustekinumab June 15, 2022 June 15, 2022 June 15, 2023
H
MP-055 Homocysteine Level Testing July 20, 2022 July 20, 2022 July 20, 2023
S
MP-069 Serologic Testing for Liver Fibrosis February 15, 2023 February 15, 2023 February 15, 2024
V
MP-056 Vitamin D Testing June 15, 2022 June 15, 2022 June 15, 2023
To Top